Healthcare is arguably defined by a continual push for better mousetraps, and LipoScience (LPDX)
may have a better mousetrap for diagnosing and characterizing heart
disease. Not only does LipoScience provide information to doctors that
other systems currently on the market do not, it does so with a platform
that offers meaningful potential value for the hospital or lab using
it. Diagnostics is a very crowded market and it is absolutely essential
that LipoScience broaden its array of assays, but this looks like a
small med-tech well worth keeping an eye on today.
Please follow the link to continue to the full article:
LipoScience - A Small Company Targeting A Large Market
No comments:
Post a Comment